(4-Bromopyridin-2-yl)methanamine → 1-Methyl-7-(piperidin-4-yl)imidazo[1,5-a]pyridine hydrochloride
反応式
[ClH:1].[NH:2]1[CH2:7][CH2:6][CH:5]([C:8]2[CH:13]=[CH:12][N:11]3[CH:14]=[N:15][CH:16]=[C:10]3[CH:9]=2)[CH2:4][CH2:3]1.Br[C:18]1C=CN=C(C(N)C)C=1.BrC1C=CN=C(CN)C=1>>[ClH:1].[CH3:18][C:16]1[N:15]=[CH:14][N:11]2[CH:12]=[CH:13][C:8]([CH:5]3[CH2:4][CH2:3][NH:2][CH2:7][CH2:6]3)=[CH:9][C:10]=12参加物
4
実験手順
The title compound was prepared using standard chemical manipulations and procedures similar to those used for the preparation of compound 39.5, except 1-(4-bromopyridin-2-yl)ethanamine (compound 66.1) was used in place of (4-bromopyridin-2-yl)methanamine (compound 39.1).
出典と根拠
- ORDレコード
- ord-54334d007fb649d4b67bfc6e5ae0c5db
- 出典データセット
- uspto-grants-2016_08
- 特許番号
- US09428502B2
反応ノート
読み込み中…